Eurofins BioPharma Services Newsletter 30 - October 2021
ARTICLES:
- Eurofins Viracor targets precision oncology with the launch of PanCancerIQ
- In Vitro potassium release assay for liposomal formulations of Amphotericin B – a requirement for Bio-IND applications
- EU MDR requires onsite Person Responsible for Regulatory Compliance
- Innovative particle size distribution and thermal analysis techniques are key to solving powder characterisation challenges
- EBPT Ireland expands footprint into high-throughput glycoprofiling of biologics with 2-AB labelling, offering development, qualification and validation services
- US Air Force awards $30 million contract to Eurofins Genomics to expand Oligonucleotide (DNA) capacity for diagnostic testing
Download the PDF version of pharma newsletter N°30
